PUBLIC CONTRACT · 2021
Pi/113/2021 fulvestrant 50 mg/ml inj im - 5ML
- Contract value
- €233,640.00
- Signed on
- 3 February 2021
- Procedure
- Open procedure (Concurso público)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7535466PUBLISHED SUBJECT
PI/113/2021 FULVESTRANT 50 MG/ML INJ IM - 5ML
Parties involved
- Awardee
- - - TEVA PHARMA - PRODUTOS FARMACÊUTICOS, LDA.
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- - - TEVA PHARMA - PRODUTOS FARMACÊUTICOS, LDA.
- Bidder
- ACCORD HEALTHCARE, Unipessoal Lda · Tax ID 508622263
- Bidder
- Teva Pharma, Lda · Tax ID 507045491
- Bidder
- BIOJAM S A · Tax ID 513642749
Values and timeline
- Contract price
- €233,640.00
- Procedure base price
- €304,590.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 5 March 2021
- Award date
- 26 January 2021
- Signing date
- 3 February 2021
- Performance period
- 340 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Open procedure (Concurso público)
- Award criterion
- Not stated
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 20.º, n.º 1, alínea a) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- 14499/2020
- Procedure identifier
- 5015375
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.